Fundraising Fox
Climb Bio Website
1 known investors
Find your way into Climb Bio Website
42 people in our graph share verified history with the Climb Bio Website team — schools, employers, funds. One of them is your warm intro.
Rahul Ballalunlockedknows Ashley Jones · together at Imara, Inc (overlapped)
×3knows the team · via SQZ Biotechnologies
×4knows the team · via Ohio Wesleyan University
×4knows the team · via Beacon Hill Staffing Group
Climb Bio develops monoclonal antibody therapies for immune-mediated diseases, advancing clinical-stage candidates such as budoprutug for conditions including immune thrombocytopenia. Its investigational therapies target patients with limited treatment options.
Founders & leadership
AB
Aoife Brennan, MB, ChBPresident and Chief Executive Officer
PW
Perrin Wilson, PhDChief Business Officer
SA
Susan Altschuller, PhD, MBAChief Financial Officer
EC
Edgar Charles, MDChief Medical Officer
AJ
Ashley JonesSenior Vice President, People & Workforce StrategySenior Vice President of People & Workforce Strategy at Climb Bio, a clinical-stage biotech company developing monoclonal antibody therapies for immune-mediated diseases.
AV
Adam Villa, MBA, MSSenior Vice President, Technical Operations
CA
Chandra Adams, JDSenior Vice President, General Counsel
Investors · 1
Frequently asked questions
- What does Climb Bio Website do?
- Climb Bio develops monoclonal antibody therapies for immune-mediated diseases, advancing clinical-stage candidates such as budoprutug for conditions including immune thrombocytopenia. Its investigational therapies target patients with limited treatment options.
- Who are Climb Bio Website's investors?
- Climb Bio Website's investors include LifeArc Ventures.